A detailed history of Balentine LLC transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Balentine LLC holds 2,471 shares of IDXX stock, worth $1.18 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
2,471
Previous 1,698 45.52%
Holding current value
$1.18 Million
Previous $942,000 41.61%
% of portfolio
0.04%
Previous 0.03%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$515.08 - $576.87 $398,156 - $445,920
773 Added 45.52%
2,471 $1.33 Million
Q4 2023

Feb 09, 2024

BUY
$391.37 - $557.56 $94,711 - $134,929
242 Added 16.62%
1,698 $942,000
Q3 2023

Nov 13, 2023

BUY
$432.42 - $556.67 $13,837 - $17,813
32 Added 2.25%
1,456 $636,000
Q2 2023

Aug 14, 2023

BUY
$450.7 - $503.61 $23,436 - $26,187
52 Added 3.79%
1,424 $715,000
Q1 2023

May 11, 2023

BUY
$406.01 - $514.59 $4,872 - $6,175
12 Added 0.88%
1,372 $686,000
Q4 2022

Jan 31, 2023

BUY
$324.64 - $441.27 $63,304 - $86,047
195 Added 16.74%
1,360 $554,000
Q3 2022

Oct 26, 2022

SELL
$325.8 - $407.78 $32,254 - $40,370
-99 Reduced 7.83%
1,165 $380,000
Q2 2022

Oct 26, 2022

BUY
$327.37 - $553.44 $49,105 - $83,016
150 Added 13.46%
1,264 $443,000
Q2 2022

Aug 15, 2022

BUY
$327.37 - $553.44 $49,105 - $83,016
150 Added 13.46%
1,264 $443,000
Q1 2022

Oct 26, 2022

SELL
$466.52 - $631.01 $69,978 - $94,651
-150 Reduced 11.87%
1,114 $609,000
Q1 2022

May 06, 2022

BUY
$466.52 - $631.01 $150,219 - $203,185
322 Added 40.66%
1,114 $609,000
Q4 2021

Oct 26, 2022

SELL
$586.54 - $666.48 $276,846 - $314,578
-472 Reduced 37.34%
792 $522,000
Q4 2021

Feb 02, 2022

BUY
$586.54 - $666.48 $38,711 - $43,987
66 Added 9.09%
792 $522,000
Q3 2021

Nov 15, 2021

BUY
$621.9 - $705.76 $26,741 - $30,347
43 Added 6.3%
726 $451,000
Q2 2021

Aug 16, 2021

BUY
$486.36 - $637.08 $40,367 - $52,877
83 Added 13.83%
683 $431,000
Q4 2020

Feb 08, 2021

SELL
$383.85 - $499.87 $4,222 - $5,498
-11 Reduced 1.8%
600 $300,000
Q3 2020

Nov 02, 2020

SELL
$334.54 - $406.31 $6,690 - $8,126
-20 Reduced 3.17%
611 $240,000
Q2 2020

Aug 14, 2020

BUY
$230.66 - $330.16 $2,075 - $2,971
9 Added 1.45%
631 $208,000
Q1 2020

May 18, 2020

SELL
$182.94 - $290.97 $28,355 - $45,100
-155 Reduced 19.95%
622 $151,000
Q4 2019

Sep 02, 2020

SELL
$248.66 - $285.01 $677,847 - $776,937
-2,726 Reduced 77.82%
777 $203,000
Q3 2019

Nov 15, 2019

SELL
$260.07 - $289.93 $6,241 - $6,958
-24 Reduced 0.68%
3,503 $953,000
Q2 2019

Aug 14, 2019

SELL
$215.53 - $275.33 $4,310 - $5,506
-20 Reduced 0.56%
3,527 $971,000
Q1 2019

May 16, 2019

SELL
$178.02 - $225.69 $14,597 - $18,506
-82 Reduced 2.26%
3,547 $796,000
Q4 2018

Feb 13, 2019

BUY
$176.18 - $248.92 $466,348 - $658,891
2,647 Added 269.55%
3,629 $675,000
Q3 2018

Nov 14, 2018

BUY
$218.82 - $254.46 $214,881 - $249,879
982 New
982 $245,000
Q1 2018

May 16, 2018

SELL
$157.81 - $204.73 $488,264 - $633,434
-3,094 Closed
0 $0
Q3 2017

Nov 15, 2017

BUY
$150.32 - $166.46 $465,090 - $515,027
3,094
3,094 $481,000

Others Institutions Holding IDXX

About IDEXX LABORATORIES INC


  • Ticker IDXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 83,253,696
  • Market Cap $39.7B
  • Description
  • IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...
More about IDXX
Track This Portfolio

Track Balentine LLC Portfolio

Follow Balentine LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balentine LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balentine LLC with notifications on news.